EQL Pharma AB (FRA:7JK) 3-Year EBITDA Growth Rate : 42.80% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is EQL Pharma AB 3-Year EBITDA Growth Rate?

EQL Pharma AB's EBITDA per Share for the three months ended in Mar. 2024 was €0.03.

During the past 12 months, EQL Pharma AB's average EBITDA Per Share Growth Rate was -17.40% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 42.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 67.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of EQL Pharma AB was 142.80% per year. The lowest was -19.50% per year. And the median was 59.95% per year.

Competitive Comparison of EQL Pharma AB's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, EQL Pharma AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EQL Pharma AB's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EQL Pharma AB's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where EQL Pharma AB's 3-Year EBITDA Growth Rate falls into.

EQL Pharma AB 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

EQL Pharma AB (FRA:7JK) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

EQL Pharma AB 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of EQL Pharma AB's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

EQL Pharma AB (FRA:7JK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EQL Pharma AB (FRA:7JK) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

EQL:Sweden

Address

Stortorget 1, 3rd Floor, Lund, SWE, 222 23

Website

http://www.eqlpharma.com

EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.

EQL Pharma AB (FRA:7JK) Headlines

No Headlines